Drug Trial Radar · NCT00494507
Hyper- and Hypokalemic Periodic Paralysis Study
Last checked: Nov 20, 2026Latest source record: Jun 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
Jun 2007
Primary completion
Apr 2013
Study completion May 2013
Sponsor
- Lead sponsor
- University of RochesterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS)
- First posted
- Jun 29, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.
Conditions
- Hyperkalemic Periodic Paralysis
- Hypokalemic Periodic Paralysis
Interventions
Dichlorphenamide (double-blind)Drug
50mg tablet; maximum dosage 400mg/day
Placebo (double-blind)Drug
Inactive substance manufactured to look like Dichlorphenamide 50mg tablet
Dichlorphenamide (open-label)Drug
50mg tablet; maximum dosage 400mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- HYP Attack RateTime frame: 8 weeks
- HOP Attack RateTime frame: 8 weeks
Locations
12 sites in 3 countries. Site status is shown where the registry gives one.
UCLA Neurology
Los Angeles, California
University of California-San Francisco
San Francisco, California
University of Kansas Medical Center
Kansas City, Kansas
Brigham & Women's Hospital
Boston, Massachusetts
Mayo Clinic
Rochester, Minnesota
Washington University School of Medicine
St Louis, Missouri
Columbia University Medical Center
New York, New York
University of Rochester
Rochester, New York
Ohio State University
Columbus, Ohio
University of Texas Southwestern-Dallas
Dallas, Texas
University of Milan
San Donato, Milan, Italy
Institute of Neurology-Queen's Square
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.